← Zurück zu Insidertransaktionen
Yu-Hsin Lin
Gemeldet als: Lin Yu-Hsin
Insider · Chief Executive Officer / Director
Käufe
0
0 USD
Verkäufe
21
19.148.376 USD
Unternehmen
1
mit gemeldeten Geschäften
Letzte Aktivität
08.09.2026
21 Transaktionen gesamt
| Datum | Unternehmen | Position | Art | Volumen | Preis | Stückzahl | Seit Meldung |
|---|---|---|---|---|---|---|---|
| 08.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 534.844,89 USD | 198,09 USD | 2.700 | – |
| 08.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.727.274,59 USD | 197,36 USD | 8.752 | – |
| 08.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.190.642,35 USD | 196,54 USD | 6.058 | – |
| 08.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.191.325,19 USD | 195,62 USD | 6.090 | – |
| 08.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 466.398,72 USD | 194,33 USD | 2.400 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.566.439,31 USD | 193,13 USD | 8.111 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 810.411,80 USD | 192,54 USD | 4.209 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 2.117.908,76 USD | 191,15 USD | 11.080 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 114.232,02 USD | 190,39 USD | 600 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.695.552,24 USD | 189,34 USD | 8.955 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 573.252,92 USD | 188,26 USD | 3.045 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.160.964,26 USD | 187,25 USD | 6.200 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.453.323,30 USD | 186,32 USD | 7.800 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 851.286,37 USD | 185,34 USD | 4.593 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.153.646,55 USD | 184,52 USD | 6.252 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 908.228,21 USD | 183,30 USD | 4.955 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 622.869,09 USD | 182,50 USD | 3.413 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 468.876,68 USD | 181,24 USD | 2.587 | – |
| 04.09.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 475.071,26 USD | 180,29 USD | 2.635 | – |
| 12.08.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 40.267,11 USD | 180,57 USD | 223 | – |
| 12.08.2026 |
Belite Bio, Inc.
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 25.560,00 USD | 180,00 USD | 142 | – |
Alle von „Lin Yu-Hsin" gemeldeten Eigengeschäfte (Directors' Dealings) gemäß Art. 19 MAR bzw. den jeweiligen nationalen Pflichtmeldungen. Gleiche Personen können unter abweichenden Schreibweisen mehrfach geführt sein. „Seit Meldung" vergleicht den aktuellen Kurs (deutsche Handelsplätze, EUR) mit dem gemeldeten EUR-Preis der Transaktion — Meldungen in anderen Währungen bleiben ohne Angabe. Details in der Methodik.